School of Medicine

Showing 1-3 of 3 Results

  • Jennifer Yi-Jiun Pan

    Jennifer Yi-Jiun Pan

    Clinical Assistant Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
    Staff, Medicine - Med/Gastroenterology and Hepatology

    BioMy research interests thus far have focused on immunology, GI cancers, and improving quality of care for patients. I am passionate about understanding the different genetic and lifestyle factors that are involved in GI cancers and other colonic pathology, as well as improving systems of care to better manage the health and improve the outcomes of patients with these diseases. Towards that end, I have been involved in research in Lynch syndrome in order to bridge the gap between our current understanding of cancer risk in this high-risk population and the creation and implementation of guidelines worldwide. I also had the opportunity to work with collaborators in the International Mismatch Repair Consortium at the Department of Colorectal Medicine and Genetics with the Royal Melbourne Hospital in Australia where I saw firsthand the global efforts in the fight against colorectal cancer. In my current role as a staff gastroenterologist at the VA Palo Alto, I oversee the colorectal cancer prevention program. My goal is to continue to be part of and contribute to collaborative clinical and research efforts in order to provide the best care for our patients.

    Selected NCBI Bibliography:

  • KT Park MD MS

    KT Park MD MS

    Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology

    BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.